Moderna (MRNA) Operating Margin: 2017-2025
Historic Operating Margin for Moderna (MRNA) over the last 8 years, with Sep 2025 value amounting to -25.59%.
- Moderna's Operating Margin fell 2183.00% to -25.59% in Q3 2025 from the same period last year, while for Sep 2025 it was -155.15%, marking a year-over-year decrease of 10146.00%. This contributed to the annual value of -121.91% for FY2024, which is 6001.00% down from last year.
- As of Q3 2025, Moderna's Operating Margin stood at -25.59%, which was up 95.99% from -638.73% recorded in Q2 2025.
- Over the past 5 years, Moderna's Operating Margin peaked at 75.02% during Q4 2021, and registered a low of -972.22% during Q1 2025.
- For the 3-year period, Moderna's Operating Margin averaged around -361.26%, with its median value being -128.99% (2024).
- In the last 5 years, Moderna's Operating Margin surged by 170,286bps in 2021 and then tumbled by 73,843bps in 2024.
- Over the past 5 years, Moderna's Operating Margin (Quarterly) stood at 75.02% in 2021, then tumbled by 4,395bps to 31.08% in 2022, then tumbled by 3,086bps to 0.21% in 2023, then tumbled by 12,920bps to -128.99% in 2024, then crashed by 2,183bps to -25.59% in 2025.
- Its last three reported values are -25.59% in Q3 2025, -638.73% for Q2 2025, and -972.22% during Q1 2025.